Basic Information
CUVRIOR
81802-001
Regulatory Information
81802-001
NDA215760
C73594
April 30, 2022
USA
These highlights do not include all the information needed to use CUVRIOR safely and effectively. See full prescribing information for CUVRIOR. CUVRIOR™ (trientine tetrahydrochloride) tablets, for oral use Initial U.S. Approval: 1985
HUMAN PRESCRIPTION DRUG LABEL
4
Company Information
263303972
Active Ingredients
MANNITOL
Code: 3OWL53L36A
Class Code: IACT
SILICON DIOXIDE
Code: ETJ7Z6XBU4
Class Code: IACT
GLYCERYL DIBEHENATE
Code: R8WTH25YS2
Class Code: IACT
Active Moieties
TRIENTINE
Code: SJ76Y07H5F